Affinity Asset Advisors, LLC
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 1773195
NEW YORK, NY
Position in MLYS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,235,000
-$82,500 QoQ
Shares Held
750,000
0.0% QoQ
Ownership
0.848%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#35
of 224 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Derivatives in MLYS
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$3,176,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. MLYS ranks #28 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in MLYS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,235,000 | 750,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,317,500 | 750,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,491,700 | 730,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,440,000 | 750,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,177,000 | 900,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,176,000 | 200,000 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $17,468,000 | 1,100,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,308,500 | 350,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,238,500 | 350,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,837,120 | 327,959 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,233,950 | 327,959 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $1,065,625 | 62,500 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $978,750 | 62,500 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||